Elevated factor VIII levels and risk of venous thrombosis

British Journal of Haematology

Volumn 157, Issue 6, 2012, Pages 653-663

  Jenkins, P Vince ^a   Rawley, Orla ^a   Smith, Owen P ^b   O'Donnell, James S ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

ABO blood group; Factor VIII; Venous thrombosis; Von willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 PLUS VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR 8C;

AGE; DISEASE COURSE; ETHNICITY; GENETIC ANALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; THROMBOGENICITY; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

CASE-CONTROL STUDIES; FACTOR IXA; FACTOR VIII; HEMOPHILIA A; HEMOSTASIS; HUMANS; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84861526902     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09134.x     Document Type: Review

References (79)

1. Antoni, G., Oudot-Mellakh, T., Dimitromanolakis, A., Germain, M., Cohen, W., Wells, P., Lathrop, M., Gagnon, F., Morange, P.E. & Tregouet, D.A. (2011) Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Medical Genetics, 12, 102.
2. Baglin, T., Gray, E., Greaves, M., Hunt, B.J., Keeling, D., Machin, S., Mackie, I., Makris, M., Nokes, T., Perry, D., Tait, R.C., Walker, I. & Watson, H.; British Committee for Standards in Haematology (2010) Clinical guidelines for testing for heritable thrombophilia. British Journal of Haematology, 49, 209-220.
3. Bank, I., Libourel, E.J., Middeldorp, S., Hamulyák, K., van Pampus, E.C., Koopman, M.M., Prins, M.H., van der Meer, J. & Büller, H.R. (2005) Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis, 3, 79-84.
4. Barcat, D., Vergnes, C., Constans, J., Boulon, C. & Conri, C. (2006) When to measure factors VIII:C and XI after an acute venous thromboembolic event? Journal of Thrombosis and Haemostasis, 4, 1631-1632.
5. Bauer, K.A., Broekmans, A.W., Bertina, R.M., Conard, J., Horellou, M.H., Samama, M.M. & Rosenberg, R.D. (1988) Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood, 71, 1418-1426.
6. Bloemenkamp, K.W., Helmerhorst, F.M., Rosendaal, F.R. & Vandenbroucke, J.P. (1999) Venous thrombosis, oral contraceptives and high factor VIII levels. Thrombosis and Haemostasis, 82, 1024-1027.
7. Bovenschen, N., Herz, J., Grimbergen, J.M., Lenting, P.J., Havekes, L.M., Mertens, K. & van Vlijmen, B.J. (2003) Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood, 101, 3933-3939.
8. Bowen, D.J., MacLean, R.M., Pellard, S. & Collins, P.W. (2001) High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated? British Journal of Haematology, 113, 655-657.
9. Butenas, S., van't Veer, C. & Mann, K.G. (1999) Normal thrombin generation. Blood, 94, 2169-2178.
10. Campos, M., Buchanan, A., Yu, F., Barbalic, M., Xiao, Y., Chambless, L.E., Wu, K.K., Folsom, A.R., Boerwinkle, E. & Dong, J.F. (2012) Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Blood, 119, 1929-1934.
11. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P., Marcucci, G. & Wu, K.K. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thrombosis and Haemostasis, 70, 380-385.
12. Cristina, L., Benilde, C., Michela, C., Mirella, F., Giuliana, G. & Gualtiero, P. (2004) High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. British Journal of Haematology, 124, 504-510.
13. Cunningham, N., Laffan, M.A., Manning, R.A. & O'Donnell, J.S. (2005) Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis. Blood Coagulation and Fibrinolysis, 16, 465-468.
14. Dahlbäck, B. (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood, 112, 19-27.
15. De Mitrio, V., Marino, R., Scaraggi, F.A., Di Bari, L., Giannoccaro, F., Petronelli, M., Ranieri, P., Tannoia, N. & Schiraldi, O. (1999) Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation. Blood Coagulation and Fibrinolysis, 10, 409-416.
16. Eischer, L., Gartner, V., Schulman, S., Kyrle, P.A. & Eichinger, S. (2009) 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology, 88, 485-490.
17. Gallinaro, L., Cattini, M.G., Sztukowska, M., Padrini, R., Sartorello, F., Pontara, E., Bertomoro, A., Daidone, V., Pagnan, A. & Casonato, A. (2008) A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood, 111, 3540-3545.
18. Gill, J.C., Endres-Brooks, J., Bauer, P.J., Marks, W.J. & Montgomery, R.R. (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood, 69, 1691-1695.
19. Goldenberg, N.A., Knapp-Clevenger, R. & Manco-Johnson, M.J.; Mountain States Regional Thrombophilia Group (2004) Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. New England Journal of Medicine, 351, 1081-1088.
20. Hoppener, M.R., Kraaijenhagen, R.A., Hutten, B.A., Büller, H.R., Peters, R.J. & Levi, M. (2004) Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. Journal of Thrombosis and Haemostasis, 2, 1316-1320.
21. Ingram, G.I. & Jones, R.V. (1966) The rise in clotting factor 8 induced in man by adrenaline: effect of alpha- and beta-blockers. Journal of Physiology, 187, 447-454.
22. Ingram, G.I., Knights, S.F., Barrow, E.M. & Dejanov, I.I. (1968) The rise in factor-8 concentration after infusion of adrenaline. British Journal of Haematology, 15, 326.
23. Jenkins, P.V. & O'Donnell, J.S. (2006) ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion, 46, 1836-1844.
24. Jones, K.C. & Mann, K.G. (1994) A model for the tissue factor pathway to thrombin. II. A mathematical simulation. Journal of Biological Chemistry, 269, 23367-23373.
25. Kamphuisen, P.W., Houwing-Duistermaat, J.J., van Houwelingen, H.H., Eikenboom, J.C., Bertina, R.M. & Rosendaal, F.R. (1998) Familial clustering of factor VIII and von Willebrand factor levels. Thrombosis and Haemostasis, 79, 323-327.
26. Kamphuisen, P.W., Eikenboom, J.C., Vos, H.L., Pablo, R., Sturk, A., Bertina, R.M. & Rosendaal, F.R. (1999) Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thrombosis and Haemostasis, 81, 680-683.
27. Kamphuisen, P.W., Rosendaal, F.R., Eikenboom, J.C., Bos, R. & Bertina, R.M. (2000a) Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels. Arteriosclerosis Thrombosis and Vascular Biology, 20, 1382-1386.
28. Kamphuisen, P.W., Lensen, R., Houwing-Duistermaat, J.J., Eikenboom, J.C., Harvey, M., Bertina, R.M. & Rosendaal, F.R. (2000b) Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. British Journal of Haematology, 109, 519-522.
29. Kamphuisen, P.W., Eikenboom, J.C., Rosendaal, F.R., Koster, T., Blann, A.D., Vos, H.L. & Bertina, R.M. (2001a) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. British Journal of Haematology, 115, 156-158.
30. Kamphuisen, P.W., Eikenboom, J.C. & Bertina, R.M. (2001b) Elevated factor VIII levels and the risk of thrombosis. Arteriosclerosis Thrombosis and Vascular Biology, 21, 731-738.
31. Kawasaki, T., Kaida, T., Arnout, J., Vermylen, J. & Hoylaerts, M.F. (1999) A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thrombosis and Haemostasis, 81, 306-311.
32. Koster, T., Blann, A.D., Briet, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152-155.
33. Kraaijenhagen, R.A., in't Anker, P.S., Koopman, M.M., Reitsma, P.H., Prins, M.H., van den Ende, A. & Buller, H.R. (2000) High plasma concentration of factor VIII:C is a major risk factor for venous thromboembolism. Thrombosis and Haemostasis, 83, 5-9.
34. Kreuz, W., Stoll, M., Junker, R., Heinecke, A., Schobess, R., Kurnik, K., Kelsch, R. & Nowak-Göttl, U. (2006) Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Arteriosclerosis, Thrombosis and Vascular Biology, 26, 1901-1906.
35. Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. & Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457-462.
36. Laffan, M.A. & Manning, R. (1996) The influence of factor VIII on measurement of activated protein C resistance. Blood Coagulation and Fibrinolysis, 7, 761-765.
37. Legnani, C., Cini, M., Cosmi, B., Poggi, M., Boggian, O. & Palareti, G. (2004) Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels. Haematologica, 89, 1347-1351.
38. Lensen, R., Bertina, R.M., Vandenbroucke, J.P. & Rosendaal, F.R. (2001) High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden. British Journal of Haematology, 114, 380-386.
39. Lenting, P.J., Neels, J.G., van den Berg, B.M., Clijsters, P.P., Meijerman, D.W., Pannekoek, H., van Mourik, J.A., Mertens, K. & van Zonneveld, A.J. (1999) The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. Journal of Biological Chemistry, 274, 23734-23739.
40. Lenting, P.J., Christophe, O.D. & Guéguen, P. (2010) The disappearing act of factor VIII. Haemophilia, 16, 6-15.
41. Machlus, K.R., Colby, E.A., Wu, J.R., Koch, G.G., Key, N.S. & Wolberg, A.S. (2009) Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thrombosis and Haemostasis, 102, 936-944.
42. Machlus, K.R., Lin, F.C. & Wolberg, A.S. (2011) Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. Blood, 118, 3960-3968.
43. Mannucci, P.M., Tripodi, A., Bottasso, B., Baudo, F., Finazzi, G., De Stefano, V., Palareti, G., Manotti, C., Mazzucconi, M.G. & Castaman, G. (1992) Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thrombosis and Haemostasis, 67, 200-202.
44. Mansvelt, E.P., Laffan, M., McVey, J.H. & Tuddenham, E.G. (1998) Analysis of the F8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis. Thrombosis and Haemostasis, 80, 561-565.
45. Martinelli, I., Bottasso, B., Duca, F., Faioni, E. & Mannucci, P.M. (1996) Heightened thrombin generation in individuals with resistance to activated protein C. Thrombosis and Haemostasis, 75, 703-705.
46. McGrath, R.T., McKinnon, T.A., Byrne, B., O'Kennedy, R., Terraube, V., McRae, E., Preston, R.J., Laffan, M.A. & O'Donnell, J.S. (2010) Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood, 115, 2666-2673.
47. McKinnon, T.A., Chion, A.C., Millington, A.J., Lane, D.A. & Laffan, M.A. (2008) N-linked glycosylation of VWF modulates its interaction with ADAMTS13. Blood, 111, 3042-3049.
48. Meijers, J.C., Tekelenburg, W.L., Bouma, B.N., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696-701.
49. Miller, C.H., Dilley, A., Richardson, L., Hooper, W.C. & Evatt, B.L. (2001) Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. American Journal of Hematology, 67, 125-129.
50. Nossent, A.Y., Dai, L., Rosendaal, F.R., Vos, H.L. & Eikenboom, J.C. (2005) Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 405-407.
51. Nossent, A.Y., Van Marion, V., Van Tilburg, N.H., Rosendaal, F.R., Bertina, R.M., Van Mourik, J.A. & Eikenboom, H.C. (2006a) von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. Journal of Thrombosis and Haemostasis, 4, 2556-2562.
52. Nossent, A.Y., Eikenboom, J.C., Vos, H.L., Bakker, E., Tanis, B.C., Doggen, C.J., Bertina, R.M. & Rosendaal, F.R. (2006b) Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis. Thrombosis and Haemostasis, 95, 942-948.
53. Nossent, A.Y., Vos, H.L., Rosendaal, F.R., Bertina, R.M. & Eikenboom, J.C. (2008) Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII. Haematologica, 93, 959-960.
54. O'Donnell, J., Tuddenham, E.G., Manning, R., Kemball-Cook, G., Johnson, D. & Laffan, M. (1997) High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thrombosis and Haemostasis, 77, 825-828.
55. O'Donnell, J., Mumford, A.D., Manning, R.A. & Laffan, M. (2000) Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thrombosis and Haemostasis, 83, 10-13.
56. O'Donnell, J., Mumford, A.D., Manning, R.A. & Laffan, M.A. (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. British Journal of Haematology, 115, 687-691.
57. O'Donnell, J., Boulton, F.E., Manning, R.A. & Laffan, M.A. (2002) Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 335-341.
58. O'Donnell, J., Manning, R.A. & Laffan, M.A. (2003) Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosis. British Journal of Haematology, 123, 139-141.
59. Oger, E., Lacut, K., Van Dreden, P., Bressollette, L., Abgrall, J.F., Blouch, M.T., Scarabin, P.Y. & Mottier, D. (2003) High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica, 88, 465-469.
60. Orstavik, K.H., Magnus, P., Reisner, H., Berg, K., Graham, J.B. & Nance, W. (1985) Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. American Journal of Human Genetics, 37, 89-101.
61. Ota, S., Yamada, N., Ogihara, Y., Tsuji, A., Ishikura, K., Nakamura, M., Wada, H. & Ito, M. (2011) High plasma level of factor VIII: an important risk factor for venous thromboembolism. Circulation Journal, 75, 1472-1475.
62. Passamonti, S.M., Bucciarelli, P., Bader, R. & Martinelli, I. (2010) Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII. Thrombosis Research, 126, 243-245.
63. Patel, R.K., Ford, E., Thumpston, J. & Arya, R. (2003) Risk factors for venous thrombosis in the black population. Thrombosis and Haemostasis, 90, 835-838.
64. Pocathikorn, A., Granath, B., Thiry, E., Van Leuven, F., Taylor, R. & Mamotte, C. (2003) Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease. Atherosclerosis, 168, 115-121.
65. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
66. Roelse, J.C., Koopman, M.M., Büller, H.R., ten Cate, J.W., Montaruli, B., van Mourik, J.A. & Voorberg, J. (1996) Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis. British Journal of Haematology, 92, 740-743.
67. Ryland, J.K., Lawrie, A.S., Mackie, I.J. & Machin, S.J. (2012) Persistent high factor VIII activity leading to increased thrombin generation - A prospective cohort study. Thrombosis Research, 129, 447-452.
68. Saenko, E.L., Yakhyaev, A.V., Mikhailenko, I., Strickland, D.K. & Sarafanov, A.G. (1999) Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. Journal of Biological Chemistry, 274, 37685-37692.
69. Schambeck, C.M., Hinney, K., Haubitz, I., Mansouri Taleghani, B., Wahler, D. & Keller, F. (2001) Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arteriosclerosis Thrombosis and Vascular Biology, 21, 289-292.
70. Schambeck, C.M., Grossmann, R., Zonnur, S., Berger, M., Teuchert, K., Spahn, A. & Walter, U. (2004) High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII. Thrombosis and Haemostasis, 92, 42-46.
71. Schönauer, V., Giannini, S., Christ, G., Quehenberger, P., Bieglmayer, C., Stain, M., Kyrle, P.A. & Weltermann, A. (2003) The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism. Thrombosis and Haemostasis, 89, 837-841.
72. Smith, N.L., Chen, M.H., Dehghan, A., Strachan, D.P., Basu, S., Soranzo, N., Hayward, C., Rudan, I., Sabater-Lleal, M., Bis, J.C., de Maat, M.P., Rumley, A., Kong, X., Yang, Q., Williams, F.M., Vitart, V., Campbell, H., Mälarstig, A., Wiggins, K.L., Van Duijn, C.M., McArdle, W.L., Pankow, J.S., Johnson, A.D., Silveira, A., McKnight, B., Uitterlinden, A.G.; Wellcome Trust Case-Control Consortium; Aleksic, N., Meigs, J.B., Peters, A., Koenig, W., Cushman, M., Kathiresan, S., Rotter, J.I., Bovill, E.G., Hofman, A., Boerwinkle, E., Tofler, G.H., Peden, J.F., Psaty, B.M., Leebeek, F., Folsom, A.R., Larson, M.G., Spector, T.D., Wright, A.F., Wilson, J.F., Hamsten, A., Lumley, T., Witteman, J.C., Tang, W. & O'Donnell, C.J. (2010) Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation, 121, 1382-1392.
73. Smith, N.L., Rice, K.M., Bovill, E.G., Cushman, M., Bis, J.C., McKnight, B., Lumley, T., Glazer, N.L., van Hylckama Vlieg, A., Tang, W., Dehghan, A., Strachan, D.P., O'Donnell, C.J., Rotter, J.I., Heckbert, S.R., Psaty, B.M. & Rosendaal, F.R. (2011) Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood, 117, 6007-6011.
74. Souto, J.C., Almasy, L., Borrell, M., Garí, M., Martínez, E., Mateo, J., Stone, W.H., Blangero, J. & Fontcuberta, J. (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation, 101, 1546-1551.
75. Terraube, V., O'Donnell, J.S. & Jenkins, P.V. (2010) Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia, 16, 3-13.
76. Tichelaar, V., Mulder, A., Kluin-Nelemans, H. & Meijer, K. (2012) The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis. Thrombosis Research, 129, 183-186.
77. Vlot, A.J., Koppelman, S.J., Meijers, J.C., Dama, C., van den Berg, H.M., Bouma, B.N., Sixma, J.J. & Willems, G.M. (1996) Kinetics of factor VIII-von Willebrand factor association. Blood, 87, 1809-1816.
78. Vormittag, R., Bencur, P., Ay, C., Tengler, T., Vukovich, T., Quehenberger, P., Mannhalter, C. & Pabinger, I. (2007) Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism. Journal of Thrombosis and Haemostasis, 5, 497-502.
79. Vormittag, R., Simanek, R., Ay, C., Dunkler, D., Quehenberger, P., Marosi, C., Zielinski, C. & Pabinger, I. (2009) High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arteriosclerosis Thrombosis and Vascular Biology, 29, 2176-2181.